PCN20 COST-OF-ILLNESS- ECONOMIC EVALUATION OF PALLIATIVE 153SM-LEXIDRONAM RADIONUCLIDE TREATMENT IN PATIENTS WITH BONE PAIN SECONDARY TO METASTATIC PROSTATE CANCER
May 1, 2007, 00:00
10.1016/S1098-3015(10)68931-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)68931-0/fulltext
Title :
PCN20 COST-OF-ILLNESS- ECONOMIC EVALUATION OF PALLIATIVE 153SM-LEXIDRONAM RADIONUCLIDE TREATMENT IN PATIENTS WITH BONE PAIN SECONDARY TO METASTATIC PROSTATE CANCER
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68931-0&doi=10.1016/S1098-3015(10)68931-0
First page :
Section Title :
Open access? :
No
Section Order :
110